By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biodesix has closed on the first of two tranches of a financing round targeting $20 million, a company spokesman confirmed today.

The Broomfield, Colo.-based companion diagnostics firm declined to provide details about the tranches, but in a document filed with the US Securities and Exchange Commission, Biodesix said that to date, it has raised $10 million in the round. The offering is in the form of equity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.